Pds biotech announces publication of preclinical research and grant of u.s. composition of matter patent for infectimune®

Preclinical research published in vaccines demonstrates infectimune ® significantly improved quantity and quality of potent multifunctional cd4 t cells compared to vaccine adjuvants

PDSB Ratings Summary

PDSB Quant Ranking